|
Base case
|
EuroFIT
|
€146,629,613
|
40,531
|
€654,611 (−73,893,166; 81,741,624)
|
126 (−1999; 2527)
|
5206
|
|
No intervention
|
€145,975,002
|
40,405
|
|
Healthcare perspective
|
EuroFIT
|
€72,489,139
|
40,531
|
€496,731 (−37,026,528; 35,107,767)
|
126 (− 2026; 2537)
|
3951
|
|
No intervention
|
€71,992,408
|
40,405
|
|
Utility values from the literature
|
EuroFIT
|
€146,629,613
|
39,767
|
€654,611 (−73,893,166; 81,741,624)
|
564 (−68; 1106)
|
1161
|
|
No intervention
|
€145,975,002
|
39,203
|
|
EuroFIT effectiveness lasts only 1 year
|
EuroFIT
|
€147,631,100
|
40,427
|
€1,759,289 (−19,869,112; 25,189,547)
|
52 (− 555; 725)
|
33,997
|
|
No intervention
|
€145,871,811
|
40,375
|
|
Time horizon 10 years
|
EuroFIT
|
€303,622,814
|
71,010
|
-€2,595,287 (−128,814,119; 137,269,728)
|
373 (− 3254; 4534)
|
Dominant
|
|
No intervention
|
€306,218,101
|
70,636
|
